Results 31 to 40 of about 2,196,135 (231)
Supplemental material, sj-tiff-1-jet-10.1177_15266028231214167 for Effect of High-Dose Drug-Coated Balloon Repetition After Drug-Coated Balloon Failure by Yusuke Tomoi, Mitsuyoshi Takahara, Yoshimitsu Soga, Taichi Hirano, Kazuki Tsunoda, Tomonori Katsuki
Tomonori Katsuki (7298834) +6 more
core +1 more source
BACKGROUND Native vessel coronary artery disease represents 1 of the most attractive fields of application for drug-coated balloons (DCBs). To date, several devices have been compared with drug-eluting stents (DESs) in this setting with different ...
B. Cortese +4 more
semanticscholar +1 more source
AIMS The best interventional strategy for the treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up are available.
D. Giacoppo +12 more
semanticscholar +1 more source
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Abstract Background and Aims Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD)
Marta B. Afonso +16 more
wiley +1 more source
Purpose: The goal of this study was to develop an ex vivo system capable of rapidly evaluating arterial drug levels in living, isolated porcine carotid arteries.Methods: A vascular bioreactor system was developed that housed a native porcine carotid ...
Kathryn Cooper +5 more
doaj +1 more source
Forest plot of (A) 6-month and (B) 12-month primary patency of access circuit in the DCB arm and the CB arm. Abbreviations: DCB, drug-coated balloon; CB, conventional balloon.
Min-Tsun Liao (4669771) +7 more
core +1 more source
Modelling drug coatings: A parallel cellular automata model of ethylcellulose-coated microspheres [PDF]
Pharmaceutical companies today face a growing demand for more complex drug designs. In the past few decades, a number of probabilistic models have been developed, with the aim of improving insight on microscopic features of these complex designs.
Crane, Martin +5 more
core +5 more sources
Forest plot of (A) 6-month and (B) 12-month primary patency of target lesion in DCB arm and CB arm. Abbreviations: DCB, drug-coated balloon; CB, conventional balloon;
Min-Tsun Liao (4669771) +7 more
core +1 more source
Forest plot of (A) 6-month and (B) 12-month target lesion primary patency of AVF only subgroup, non-central venous stenosis subgroup, and AVF and non-central venous stenosis subgroup. Abbreviations: DCB, drug-coated balloon; CB, conventional balloon; CVS,
Min-Tsun Liao (4669771) +7 more
core +1 more source
Background Peripheral arterial disease is a progressive atherosclerotic disease with symptoms ranging from an intermittent claudication to acute critical limb ischemia and amputations. Drug-coated balloons and stents were developed to prevent neo-intimal
Stefano Barco +12 more
doaj +1 more source

